Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Procter & Gamble Co., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Accounts payable	15,227)	14,512)	14,495)	15,350)	15,364)	13,691)	14,234)	14,435)	14,598)	13,790)	14,153)	14,845)	14,882)	14,175)	14,154)	14,223)	13,720)	12,134)	12,027)	11,935)	12,071)	10,464)	10,781)	10,951)
Accrued and other liabilities	11,318)	9,847)	9,878)	10,661)	11,072)	10,920)	11,100)	10,912)	10,929)	10,523)	10,293)	10,056)	9,554)	10,324)	10,542)	10,377)	10,523)	11,109)	11,131)	10,366)	9,722)	9,731)	10,230)	9,950)
Debt due within one year	9,513)	9,889)	9,424)	10,409)	7,191)	7,729)	10,616)	11,811)	10,229)	13,717)	14,300)	11,717)	8,645)	9,902)	13,331)	11,989)	8,889)	8,773)	8,586)	7,707)	11,183)	12,701)	9,153)	9,352)
Current liabilities	36,058)	34,248)	33,797)	36,420)	33,627)	32,340)	35,950)	37,158)	35,756)	38,030)	38,746)	36,618)	33,081)	34,401)	38,027)	36,589)	33,132)	32,016)	31,744)	30,008)	32,976)	32,896)	30,164)	30,253)
Long-term debt, excluding due within one year	24,995)	24,252)	25,263)	25,744)	25,269)	24,253)	23,096)	24,069)	24,378)	22,874)	20,582)	21,286)	22,848)	23,767)	22,322)	20,558)	23,099)	21,053)	22,514)	23,948)	23,537)	23,310)	18,985)	20,161)
Deferred income taxes	5,774)	6,481)	6,725)	6,420)	6,516)	6,284)	6,219)	6,814)	6,478)	6,422)	6,462)	6,986)	6,809)	6,543)	6,506)	6,323)	6,153)	5,977)	6,073)	6,294)	6,199)	6,309)	6,242)	6,325)
Other noncurrent liabilities	6,119)	5,458)	5,410)	5,757)	6,399)	6,387)	6,615)	6,476)	7,152)	7,104)	7,200)	7,058)	7,616)	9,760)	9,668)	9,791)	10,269)	10,813)	11,241)	11,073)	11,110)	10,104)	10,424)	10,335)
Noncurrent liabilities	36,888)	36,191)	37,398)	37,921)	38,184)	36,924)	35,930)	37,359)	38,008)	36,400)	34,244)	35,330)	37,273)	40,070)	38,496)	36,672)	39,521)	37,843)	39,828)	41,315)	40,846)	39,723)	35,651)	36,821)
Total liabilities	72,946)	70,439)	71,195)	74,341)	71,811)	69,264)	71,880)	74,517)	73,764)	74,430)	72,990)	71,948)	70,354)	74,471)	76,523)	73,261)	72,653)	69,859)	71,572)	71,323)	73,822)	72,619)	65,815)	67,074)
Preferred stock	777)	781)	788)	791)	798)	801)	809)	812)	819)	822)	831)	834)	843)	846)	856)	859)	870)	873)	885)	888)	897)	900)	911)	915)
Common stock	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)
Additional paid-in capital	68,770)	68,615)	68,283)	68,102)	67,684)	67,395)	66,935)	66,822)	66,556)	66,316)	66,145)	65,955)	65,795)	65,614)	65,432)	65,148)	64,848)	64,682)	64,672)	64,467)	64,194)	63,976)	64,019)	63,949)
Reserve for ESOP debt retirement	(672)	(672)	(707)	(707)	(737)	(737)	(782)	(782)	(821)	(821)	(870)	(870)	(916)	(916)	(965)	(964)	(1,006)	(1,006)	(1,072)	(1,046)	(1,080)	(1,080)	(1,112)	(1,112)
Accumulated other comprehensive loss	(12,143)	(11,307)	(11,637)	(10,893)	(11,900)	(12,370)	(12,167)	(12,583)	(12,220)	(12,266)	(12,506)	(12,811)	(12,189)	(13,448)	(13,564)	(14,062)	(13,744)	(15,489)	(15,091)	(15,881)	(16,165)	(15,916)	(14,942)	(15,298)
Treasury stock	(138,702)	(138,073)	(137,112)	(134,823)	(133,378)	(132,172)	(131,886)	(131,028)	(129,736)	(130,002)	(129,012)	(127,205)	(123,382)	(122,272)	(121,543)	(117,240)	(114,973)	(112,147)	(109,583)	(106,794)	(105,573)	(105,823)	(105,761)	(102,510)
Retained earnings	129,973)	128,919)	127,544)	125,361)	123,811)	123,132)	121,617)	120,443)	118,170)	117,082)	115,858)	114,163)	112,429)	111,645)	110,393)	108,361)	106,374)	105,674)	104,361)	102,539)	100,239)	99,474)	98,414)	96,625)
Shareholders’ equity attributable to Procter & Gamble	52,012)	52,272)	51,168)	51,840)	50,287)	50,058)	48,535)	47,693)	46,777)	45,140)	44,455)	44,075)	46,589)	45,478)	44,618)	46,111)	46,378)	46,596)	48,181)	48,182)	46,521)	45,540)	45,538)	46,578)
Noncontrolling interest	272)	273)	275)	301)	272)	275)	294)	321)	288)	281)	270)	259)	265)	268)	275)	297)	276)	323)	359)	394)	357)	401)	370)	406)
Total shareholders’ equity	52,284)	52,545)	51,443)	52,141)	50,559)	50,333)	48,829)	48,014)	47,065)	45,421)	44,725)	44,334)	46,854)	45,746)	44,893)	46,408)	46,654)	46,919)	48,540)	48,576)	46,878)	45,941)	45,908)	46,984)
Total liabilities and shareholders’ equity	125,230)	122,984)	122,638)	126,482)	122,370)	119,597)	120,709)	122,531)	120,829)	119,851)	117,715)	116,282)	117,208)	120,217)	121,416)	119,669)	119,307)	116,778)	120,112)	119,899)	120,700)	118,560)	111,723)	114,058)

The financial data reflects the company's quarterly performance over multiple years, revealing various trends in liabilities and equity components.

Accounts payable: The accounts payable showed a general upward trend from US$10,951 million in September 2019 to a peak around US$15,364 million in June 2024, though with some fluctuations. This indicates increasing short-term payment obligations over the years.
Accrued and other liabilities: This category fluctuated moderately, ranging from about US$9,550 million to US$11,100 million, with no clear consistent trend, suggesting stable but varying obligations accrued over the periods.
Debt due within one year: Short-term debt saw significant variation, moving from approximately US$9,352 million in September 2019 to a higher range near US$10,000–14,000 million in later periods, peaking in December 2022 at US$14,300 million before declining again. This implies fluctuating short-term financing needs.
Current liabilities: Current liabilities showed an overall increasing trend, rising from about US$30,253 million in September 2019 to highs near US$38,746 million in December 2022, followed by moderate declines and fluctuations thereafter, indicating growth in short-term liabilities.
Long-term debt, excluding due within one year: Long-term debt experienced some fluctuation with a range from about US$18,985 million to US$25,744 million, peaking between 2024 and 2025, reflecting a dynamic debt management approach with increased issuance or refinancing.
Deferred income taxes: Deferred income taxes remained relatively stable within a narrow band around US$6,000–7,000 million, with minor fluctuations suggesting consistent tax deferral activities.
Other noncurrent liabilities: Other noncurrent liabilities decreased notably from US$10,335 million in late 2019 to approximately US$5,410 million in 2024, indicating reductions in long-term obligations outside of debt and deferred taxes.
Noncurrent liabilities: Overall noncurrent liabilities displayed mixed trends, peaking around US$41,315 million in late 2020 before declining to mid-30 billion levels from 2022 onward, reflecting paydowns or reclassifications of liabilities.
Total liabilities: Total liabilities rose significantly from US$67,074 million in September 2019 to about US$76,523 million in December 2021, then moderated to approximately US$69,264 million in September 2023 but surged again to over US$74,000 million by mid-2025, indicating ongoing liabilities growth with some periodical reductions.
Preferred and common stock: Preferred stock steadily decreased slightly from US$915 million to US$777 million over the years, while common stock remained constant at US$4,009 million, demonstrating no new issuance or repurchase of common stock but a gradual reduction in preferred stock.
Additional paid-in capital: This equity component steadily increased from approximately US$63,949 million to US$68,770 million, reflecting ongoing capital infusions or retained earnings allocated as paid-in capital.
Reserve for ESOP debt retirement: The reserve steadily improved from around -US$1,112 million to -US$672 million, signaling reductions in employee stock ownership plan-related debt obligations.
Accumulated other comprehensive loss: Accumulated other comprehensive loss showed some volatility but generally improved, moving from roughly -US$15,298 million to about -US$12,143 million, indicating a reduction in comprehensive losses.
Treasury stock: Treasury stock increased substantially in absolute value from approximately -US$102,510 million to nearly -US$138,702 million, highlighting ongoing share repurchases or treasury stock accumulation.
Retained earnings: Retained earnings consistently increased from US$96,625 million to US$129,973 million, demonstrating the company's sustained profitability and earnings retention over the period.
Shareholders’ equity attributable to the company: This component experienced slight fluctuations but overall positive growth from US$46,578 million in late 2019 to around US$52,012 million by early 2025, indicating growth in equity value attributable to shareholders.
Noncontrolling interest: Noncontrolling interest remained relatively minimal and stable, varying between US$272 million and US$406 million, suggesting limited impact from minority interests.
Total shareholders’ equity: The total shareholders' equity followed an upward trajectory from approximately US$46,984 million to over US$52,284 million, consistent with increased capitalization and retained earnings.
Total liabilities and shareholders’ equity: This total balanced figure increased overall from roughly US$114,058 million to US$125,230 million, reflecting growth in the company's combined liabilities and equity base over time.

In summary, the data displays sustained growth in total liabilities and shareholders' equity, with noticeable increases in treasury stock and retained earnings. Short-term and long-term debt show variability indicative of active financial management. The improvement in accumulated other comprehensive loss and reserve for ESOP debt retirement points to enhanced financial health in specific areas. The trends suggest the company has been strengthening its equity position while managing liabilities and capital structure dynamically.

Download chart

Procter & Gamble Co. (NYSE:PG)

Balance Sheet: Liabilities and Stockholders’ Equity Quarterly Data

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data